These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 303343)

  • 1. Action of humoral factors derived from acute and chronic myeloid leukemic cells on in vitro myelopoiesis.
    Hinterberger W; Mittermayer K; Kinast H; Paukovits WR
    Oncology; 1977; 34(5):193-7. PubMed ID: 303343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marrow adherent cell colony-stimulating activity production in acute myeloid leukemia.
    Greenberg PL; Mara B; Heller P
    Blood; 1978 Aug; 52(2):362-78. PubMed ID: 307417
    [No Abstract]   [Full Text] [Related]  

  • 3. Production of colony-stimulating factor by leukemic leukocytes.
    Goldman JM; Th'ng KH; Catovsky D; Galton DA
    Blood; 1976 Mar; 47(3):381-8. PubMed ID: 1082779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of humoral regulators on proliferation and maturation of normal and leukemic cells.
    Karp JE; Burke PJ
    Cancer Res; 1976 May; 36(5):1674-9. PubMed ID: 1063598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial stimulation and granulocyte inhibition of granulopoietic factor production.
    Robinson WA; Entringer MA; Bolin RW; Stonington OG
    N Engl J Med; 1977 Nov; 297(21):1129-34. PubMed ID: 21349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antigen shared by human granulocytes, monocytes, marrow granulocyte precursors and leukemic blasts.
    Shumak KH; Rachkewich RA
    Acta Haematol; 1983; 69(3):164-70. PubMed ID: 6404099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and responsiveness of human granulocytic leukemic cells in vitro.
    Metcalf D; Moore MA
    Bibl Haematol; 1975; (40):235-41. PubMed ID: 1057945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloblastic leukemic cells causing suppression of granulopoiesis and excessive binding of colony-stimulating activity. The effect of antithymocyte globulin.
    Craddock CG; Rodensky D; Forsén NR; Kaspersky CJ; Sparkes RS
    Am J Med; 1978 Feb; 64(2):343-53. PubMed ID: 305203
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification and properties of cytidine deaminase from normal and leukemic granulocytes.
    Chabner BA; Johns DG; Coleman CN; Drake JC; Evans WH
    J Clin Invest; 1974 Mar; 53(3):922-31. PubMed ID: 4521417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Communication between white cells and the abnormalities of this in leukemia.
    Broxmeyer HE; Moore MA
    Biochim Biophys Acta; 1978 Oct; 516(2):129-66. PubMed ID: 365238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of inhibitor released from neutrophils and leukemic blast cells.
    Galbraith PR; Cooke LJ; Baker FL
    Can Med Assoc J; 1979 Mar; 120(5):545-55. PubMed ID: 312135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal colony stimulating factor (CSF) production by bone marrow stromal cells and abnormal granulopoiesis with decreased CFUc in S1/S1d mice.
    Knospe WH; Hinrichs B; Fried W; Robinson W; Trobaugh FE
    Exp Hematol; 1976 May; 4(3):125-30. PubMed ID: 1083808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of bone marrow cell growth in diffusion chambers: the effect of adding normal and leukemic (CML) polymorphonuclear granulocytes.
    Böyum A; Lövhaug D; Boecker WR
    Blood; 1976 Sep; 48(3):373-83. PubMed ID: 1066174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of colony-stimulating activities for evaluating in vitro granulomonopoiesis in normal subjects and in patients with myeloid leukemias.
    López-Karpovitch X; Padrós-Semorile MR; Hurtado-Monroy R; Cárdenas MR; Niesvizky N; Martínez-Sánchez L; Rojas R
    Rev Invest Clin; 1985; 37(4):323-7. PubMed ID: 3879370
    [No Abstract]   [Full Text] [Related]  

  • 15. Production, characteristics and mode of action of hemopoietic growth inhibitors in myeloid leukemias.
    Olsson I; Olofsson T
    Med Oncol Tumor Pharmacother; 1985; 2(1):1-6. PubMed ID: 3877222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral function of acute leukaemic blasts.
    Hinterberger W; Fischauf H; Kletter K; Paukovits W; Bais P
    Scand J Haematol; 1977 Jul; 19(1):121-8. PubMed ID: 302026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of monoclonal antibodies against primary myeloid granules in normal and leukemic cells.
    Elghetany MT; Sullivan AK; Kurec AS; MacCallum JM; Bloomfield CD; Sobol RE; Davey FR
    Am J Clin Pathol; 1992 Oct; 98(4):430-6. PubMed ID: 1415023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The determination of myeloid-committed stem cells in systemic disorders of myelopoiesis: implications for physiopathology, diagnosis and prognosis].
    Hinterberger W
    Acta Med Austriaca Suppl; 1981; 21():1-20. PubMed ID: 6949436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
    Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.